Nucleic Acid Isolation and Purification Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product ; By Type ; By Method ; By Application ; By End User ; By Region

Description

Global Nucleic Acid Isolation and Purification Market Size Expands at Significant CAGR of 9.23% to Reach USD 8.47 Billion by 2030

Global Nucleic Acid Isolation and Purification Market is flourishing because of the expanding pipeline for RNA therapeutics and growing popularity of nucleic acid-based diagnostics.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Nucleic Acid Isolation and Purification Market size at USD 4.22 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Nucleic Acid Isolation and Purification Market size to expand at a CAGR of 9.23% reaching a value of USD 8.47 billion by 2030. Growing R&D efforts and an increase in the use of sequencing platforms for clinical diagnostics are two key growth drivers for the Global Nucleic Acid Isolation and Purification Market. The is also expected to be driven by an increase in genomics research as well as new product launches.

Opportunity: Rising application for diagnostics

The Global Nucleic Acid Isolation and Purification Market is segmented into drug discovery & development, precision medicine, diagnostics, agriculture and animal research, and other, based on application. The diagnostics segment holds the largest share in the Global Nucleic Acid Isolation and Purification Market. According to research published on ScienceDirect, RNA/DNA genetic tests are the most reliable for identifying infectious illnesses and determining a person's vulnerability to certain diseases, including COVID-19. Drug discovery and development is anticipated to register the highest growth rate during the forecast period.

Impact of Escalating Geopolitical Tensions on Global Nucleic Acid Isolation and Purification Market

The escalating geopolitical tensions restrict the growth of the Global Nucleic Acid Isolation and Purification Market. For instance, Ukraine has been emerging as the leading destination for clinical research and trials of various diseases, particularly cancer. The presence of an organized and digitized health system makes it cheaper to accommodate medical research in Ukraine compared to many other Western European nations. However, Russia's invasion of Ukraine disrupted the medical research ecosystem in the country. Many reports reveal that Ukraine has a large number of clinical research specialists as well as infrastructure, which directly impacts the demand for nucleic acid isolation and purification, hindering its global market growth.

Global Nucleic Acid Isolation and Purification Market

Segmental Coverage

Global Nucleic Acid Isolation and Purification Market - By Method

Based on method, the Global Nucleic Acid Isolation and Purification Market is segmented into reagent-based isolation & purification, column-based isolation & purification, magnetic bead-based isolation and purification, and others. The magnetic bead-based isolation and purification segment accounts for the highest market share due to improved assay performance in DNA and RNA isolation and purification. Additionally, this method is also faster, easier, and more flexible compared to other methods, which gives it a competitive edge over other methods, and therefore, is preferred by researchers and scientists.

Global Nucleic Acid Isolation and Purification Market - By Region

The in-depth research report on the Global Nucleic Acid Isolation and Purification Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, the Middle East and Africa. North America dominates the Global Nucleic Acid Isolation and Purification Market. The high concentration of major industry players, such as Thermo Scientific and Bio-Rad Laboratories Inc., and their increasing efforts and investments in the R&D of nucleic acid purification systems are driving the market.

Competitive Landscape

Major players operating in the Global Nucleic Acid Isolation and Purification Market include Agilent Technologies, Bio-Rad Laboratories Inc., Thermo Fisher Scientific, BioVision Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, GE Healthcare, Merck KGaA (Sigma-Aldrich Corporation), Promega Corporation, Qiagen NV, Invitek Molecular, Analytik Jena AG, Illumina, Inc., and Takara Bio Inc.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Nucleic Acid Isolation and Purification Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Nucleic Acid Isolation and Purification Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC24238

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Nucleic Acid Isolation and Purification Market Insights

3.1. Industry Value Chain Analysis
- 3.1.1. DROC Analysis
- 3.1.2. Growth Drivers
  - 3.1.2.1. Expanding Pipeline for RNA Therapeutics
  - 3.1.2.2. Growing Popularity of Nucleic Acid-based Diagnostics
  - 3.1.2.3. Technological Advancements
  - 3.1.2.4. Increasing Research Activities
- 3.1.3. Restraints
  - 3.1.3.1. Regulatory Challenges
  - 3.1.3.2. Cost Constraints
  - 3.1.3.3. Supply Chain Disruptions
- 3.1.4. Opportunities
  - 3.1.4.1. Advanced Diagnostic Techniques Demand
  - 3.1.4.2. Strategic Collaborations
  - 3.1.4.3. Market Expansion in Developing Regions
- 3.1.5. Challenges
  - 3.1.5.1. High Competition
  - 3.1.5.2. Technological Complexity
3.2. Technological Advancements/Recent Developments
3.3. Regulatory Framework
3.4. Porter's Five Forces Analysis
- 3.4.1. Bargaining Power of Suppliers
- 3.4.2. Bargaining Power of Buyers
- 3.4.3. Threat of New Entrants
- 3.4.4. Threat of Substitutes
- 3.4.5. Intensity of Rivalry

4. Global Nucleic Acid Isolation and Purification Market, Pricing Analysis

5. Global Nucleic Acid Isolation and Purification Market: Marketing Strategies

6. Global Nucleic Acid Isolation and Purification Market, Geographical Analysis

6.1. Global Nucleic Acid Isolation and Purification Market, Geographical Analysis, 2023
6.2. Global Lateral Flow Assays, Market Attractiveness Analysis, 2024-2030

7. Global Nucleic Acid Isolation and Purification Market Overview

7.1. Market End User & Forecast, 2019-2030
- 7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
- 7.2.1. By Product
  - 7.2.1.1. Kits & Reagents
  - 7.2.1.2. Instruments
  - 7.2.1.3. Others
- 7.2.2. By Type
  - 7.2.2.1. Plasmid DNA Isolation & Purification
  - 7.2.2.2. Total RNA Isolation & Purification
  - 7.2.2.3. Genomic DNA Isolation & Purification
  - 7.2.2.4. Messenger RNA Isolation & Purification
  - 7.2.2.5. Micro RNA Isolation & Purification
  - 7.2.2.6. Circulating Nucleic Acid Isolation & Purification
  - 7.2.2.7. PCR Cleanup
  - 7.2.2.8. Others
- 7.2.3. By Method
  - 7.2.3.1. Reagent-based Isolation & Purification
  - 7.2.3.2. Column-based Isolation & Purification
  - 7.2.3.3. Magnetic Bead-based Isolation & Purification
  - 7.2.3.4. Others
- 7.2.4. By Application
  - 7.2.4.1. Drug Discovery & Development
  - 7.2.4.2. Precision Medicine
  - 7.2.4.3. Diagnostics
  - 7.2.4.4. Agriculture & Animal Research
  - 7.2.4.5. Others
- 7.2.5. By End User
  - 7.2.5.1. Hospitals
  - 7.2.5.2. Diagnostic Centers
  - 7.2.5.3. Academic & Research Institutes
  - 7.2.5.4. Contract Research Organizations
  - 7.2.5.5. Pharmaceutical & Biotechnology Companies
  - 7.2.5.6. Others
- 7.2.6. By Region
  - 7.2.6.1. North America
  - 7.2.6.2. Europe
  - 7.2.6.3. Asia Pacific (APAC)
  - 7.2.6.4. Latin America (LATAM)
  - 7.2.6.5. Middle East and Africa (MEA)

8. North America Nucleic Acid Isolation and Purification Market

8.1. Market End User & Forecast, 2019-2030
- 8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Type
- 8.2.3. By Method
- 8.2.4. By Application
- 8.2.5. By End User
- 8.2.6. By Country
  - 8.2.6.1. United States
  - 8.2.6.1.1. By Product
  - 8.2.6.1.2. By Type
  - 8.2.6.1.3. By Method
  - 8.2.6.1.4. By Application
  - 8.2.6.1.5. By End User
  - 8.2.6.2. Canada
  - 8.2.6.2.1. By Product
  - 8.2.6.2.2. By Type
  - 8.2.6.2.3. By Method
  - 8.2.6.2.4. By Application
  - 8.2.6.2.5. By End User

9. Europe Nucleic Acid Isolation and Purification Market

9.1. Market End User & Forecast, 2019-2030
- 9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Type
- 9.2.3. By Method
- 9.2.4. By Application
- 9.2.5. By End User
- 9.2.6. By Country
  - 9.2.6.1. Germany
  - 9.2.6.1.1. By Product
  - 9.2.6.1.2. By Type
  - 9.2.6.1.3. By Method
  - 9.2.6.1.4. By Application
  - 9.2.6.1.5. By End User
  - 9.2.6.2. United Kingdom
  - 9.2.6.2.1. By Product
  - 9.2.6.2.2. By Type
  - 9.2.6.2.3. By Method
  - 9.2.6.2.4. By Application
  - 9.2.6.2.5. By End User
  - 9.2.6.3. Italy
  - 9.2.6.3.1. By Product
  - 9.2.6.3.2. By Type
  - 9.2.6.3.3. By Method
  - 9.2.6.3.4. By Application
  - 9.2.6.3.5. By End User
  - 9.2.6.4. France
  - 9.2.6.4.1. By Product
  - 9.2.6.4.2. By Type
  - 9.2.6.4.3. By Method
  - 9.2.6.4.4. By Application
  - 9.2.6.4.5. By End User
  - 9.2.6.5. Spain
  - 9.2.6.5.1. By Product
  - 9.2.6.5.2. By Type
  - 9.2.6.5.3. By Method
  - 9.2.6.5.4. By Application
  - 9.2.6.5.5. By End User
  - 9.2.6.6. Belgium
  - 9.2.6.6.1. By Product
  - 9.2.6.6.2. By Type
  - 9.2.6.6.3. By Method
  - 9.2.6.6.4. By Application
  - 9.2.6.6.5. By End User
  - 9.2.6.7. Russia
  - 9.2.6.7.1. By Product
  - 9.2.6.7.2. By Type
  - 9.2.6.7.3. By Method
  - 9.2.6.7.4. By Application
  - 9.2.6.7.5. By End User
  - 9.2.6.8. The Netherlands
  - 9.2.6.8.1. By Product
  - 9.2.6.8.2. By Type
  - 9.2.6.8.3. By Method
  - 9.2.6.8.4. By Application
  - 9.2.6.8.5. By End User
  - 9.2.6.9. Rest of Europe
  - 9.2.6.9.1. By Product
  - 9.2.6.9.2. By Type
  - 9.2.6.9.3. By Method
  - 9.2.6.9.4. By Application
  - 9.2.6.9.5. By End User

10. Asia Pacific Nucleic Acid Isolation and Purification Market

10.1. Market End User & Forecast, 2019-2030
- 10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Type
- 10.2.3. By Method
- 10.2.4. By Application
- 10.2.5. By End User
- 10.2.6. By Country
  - 10.2.6.1. China
  - 10.2.6.1.1. By Product
  - 10.2.6.1.2. By Type
  - 10.2.6.1.3. By Method
  - 10.2.6.1.4. By Application
  - 10.2.6.1.5. By End User
  - 10.2.6.2. India
  - 10.2.6.2.1. By Product
  - 10.2.6.2.2. By Type
  - 10.2.6.2.3. By Method
  - 10.2.6.2.4. By Application
  - 10.2.6.2.5. By End User
  - 10.2.6.3. Japan
  - 10.2.6.3.1. By Product
  - 10.2.6.3.2. By Type
  - 10.2.6.3.3. By Method
  - 10.2.6.3.4. By Application
  - 10.2.6.3.5. By End User
  - 10.2.6.4. South Korea
  - 10.2.6.4.1. By Product
  - 10.2.6.4.2. By Type
  - 10.2.6.4.3. By Method
  - 10.2.6.4.4. By Application
  - 10.2.6.4.5. By End User
  - 10.2.6.5. Australia & New Zealand
  - 10.2.6.5.1. By Product
  - 10.2.6.5.2. By Type
  - 10.2.6.5.3. By Method
  - 10.2.6.5.4. By Application
  - 10.2.6.5.5. By End User
  - 10.2.6.6. Indonesia
  - 10.2.6.6.1. By Product
  - 10.2.6.6.2. By Type
  - 10.2.6.6.3. By Method
  - 10.2.6.6.4. By Application
  - 10.2.6.6.5. By End User
  - 10.2.6.7. Malaysia
  - 10.2.6.7.1. By Product
  - 10.2.6.7.2. By Type
  - 10.2.6.7.3. By Method
  - 10.2.6.7.4. By Application
  - 10.2.6.7.5. By End User
  - 10.2.6.8. Singapore
  - 10.2.6.8.1. By Product
  - 10.2.6.8.2. By Type
  - 10.2.6.8.3. By Method
  - 10.2.6.8.4. By Application
  - 10.2.6.8.5. By End User
  - 10.2.6.9. Vietnam
  - 10.2.6.9.1. By Product
  - 10.2.6.9.2. By Type
  - 10.2.6.9.3. By Method
  - 10.2.6.9.4. By Application
  - 10.2.6.9.5. By End User
  - 10.2.6.10. Rest of APAC
  - 10.2.6.10.1. By Product
  - 10.2.6.10.2. By Type
  - 10.2.6.10.3. By Method
  - 10.2.6.10.4. By Application
  - 10.2.6.10.5. By End User

11. Latin America Nucleic Acid Isolation and Purification Market

11.1. Market End User & Forecast, 2019-2030
- 11.1.1. By Value (USD Billion)
11.2. Market Share & Forecast
- 11.2.1. By Product
- 11.2.2. By Type
- 11.2.3. By Method
- 11.2.4. By Application
- 11.2.5. By End User
- 11.2.6. By Country
  - 11.2.6.1. Brazil
  - 11.2.6.1.1. By Product
  - 11.2.6.1.2. By Type
  - 11.2.6.1.3. By Method
  - 11.2.6.1.4. By Application
  - 11.2.6.1.5. By End User
  - 11.2.6.2. Mexico
  - 11.2.6.2.1. By Product
  - 11.2.6.2.2. By Type
  - 11.2.6.2.3. By Method
  - 11.2.6.2.4. By Application
  - 11.2.6.2.5. By End User
  - 11.2.6.3. Argentina
  - 11.2.6.3.1. By Product
  - 11.2.6.3.2. By Type
  - 11.2.6.3.3. By Method
  - 11.2.6.3.4. By Application
  - 11.2.6.3.5. By End User
  - 11.2.6.4. Peru
  - 11.2.6.4.1. By Product
  - 11.2.6.4.2. By Type
  - 11.2.6.4.3. By Method
  - 11.2.6.4.4. By Application
  - 11.2.6.4.5. By End User
  - 11.2.6.5. Rest of LATAM
  - 11.2.6.5.1. By Product
  - 11.2.6.5.2. By Type
  - 11.2.6.5.3. By Method
  - 11.2.6.5.4. By Application
  - 11.2.6.5.5. By End User

12. Middle East and Africa Nucleic Acid Isolation and Purification Market

12.1. Market End User & Forecast, 2019-2030
- 12.1.1. By Value (USD Billion)
12.2. Market Share & Forecast
- 12.2.1. By Product
- 12.2.2. By Type
- 12.2.3. By Method
- 12.2.4. By Application
- 12.2.5. By End User
- 12.2.6. By Country
  - 12.2.6.1. Saudi Arabia
  - 12.2.6.1.1. By Product
  - 12.2.6.1.2. By Type
  - 12.2.6.1.3. By Method
  - 12.2.6.1.4. By Application
  - 12.2.6.1.5. By End User
  - 12.2.6.2. UAE
  - 12.2.6.2.1. By Product
  - 12.2.6.2.2. By Type
  - 12.2.6.2.3. By Method
  - 12.2.6.2.4. By Application
  - 12.2.6.2.5. By End User
  - 12.2.6.3. Qatar
  - 12.2.6.3.1. By Product
  - 12.2.6.3.2. By Type
  - 12.2.6.3.3. By Method
  - 12.2.6.3.4. By Application
  - 12.2.6.3.5. By End User
  - 12.2.6.4. Kuwait
  - 12.2.6.4.1. By Product
  - 12.2.6.4.2. By Type
  - 12.2.6.4.3. By Method
  - 12.2.6.4.4. By Application
  - 12.2.6.4.5. By End User
  - 12.2.6.5. South Africa
  - 12.2.6.5.1. By Product
  - 12.2.6.5.2. By Type
  - 12.2.6.5.3. By Method
  - 12.2.6.5.4. By Application
  - 12.2.6.5.5. By End User
  - 12.2.6.6. Nigeria
  - 12.2.6.6.1. By Product
  - 12.2.6.6.2. By Type
  - 12.2.6.6.3. By Method
  - 12.2.6.6.4. By Application
  - 12.2.6.6.5. By End User
  - 12.2.6.7. Algeria
  - 12.2.6.7.1. By Product
  - 12.2.6.7.2. By Type
  - 12.2.6.7.3. By Method
  - 12.2.6.7.4. By Application
  - 12.2.6.7.5. By End User
  - 12.2.6.8. Rest of MEA
  - 12.2.6.8.1. By Product
  - 12.2.6.8.2. By Type
  - 12.2.6.8.3. By Method
  - 12.2.6.8.4. By Application
  - 12.2.6.8.5. By End User

13. Competitive Landscape

13.1. List of Key Players and Their Methods
13.2. Global Nucleic Acid Isolation and Purification Company Market Share Analysis, 2023
13.3. Competitive Benchmarking, By Operating Parameters
13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

14. Impact of Escalating Geopolitical Tensions on Global Nucleic Acid Isolation and Purification Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

15.1. Agilent Technologies
15.2. Bio-Rad Laboratories Inc.
15.3. Thermo Fisher Scientific
15.4. BioVision Inc.
15.5. Danaher Corporation
15.6. F. Hoffmann-La Roche Ltd
15.7. GE Healthcare
15.8. Merck KGaA (Sigma-Aldrich Corporation)
15.9. Promega Corporation
15.10. Qiagen NV
15.11. Invitek Molecular
15.12. Analytik Jena AG
15.13. Illumina, Inc
15.14. Takara Bio Inc.
15.15. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

17.1. Qualitative Research
- 17.1.1. Primary & Secondary Research
17.2. Quantitative Research
17.3. Market Breakdown & Data Triangulation
- 17.3.1. Secondary Research
- 17.3.2. Primary Research
17.4. Breakdown of Primary Research Respondents, By Region
17.5. Assumptions & Limitations